BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30229909)

  • 1. Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.
    Elias KM; Tsantoulis P; Tille JC; Vitonis A; Doyle LA; Hornick JL; Kaya G; Barnes L; Cramer DW; Puppa G; Stuckelberger S; Hooda J; Dietrich PY; Goggins M; Kerr CL; Birrer M; Hirsch MS; Drapkin R; Labidi-Galy SI
    J Pathol; 2018 Dec; 246(4):459-469. PubMed ID: 30229909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas.
    Yeh MM; Tang LH; Wang S; Robert ME; Zheng W; Jain D
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):148-52. PubMed ID: 15354741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
    Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
    J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Aoki T; Murakami M; Mizukami H; Tanaka JI; Takimoto M
    Anticancer Res; 2017 Dec; 37(12):7063-7068. PubMed ID: 29187496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple KRAS mutations in the non-mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas.
    An S; Kim MJ; Kim SJ; Sung YN; Kim YW; Song KB; Hwang DW; Kim SC; Hruban RH; Hong SM
    Histopathology; 2019 Oct; 75(4):559-567. PubMed ID: 31077597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
    Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
    Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of steroidogenic enzymes in ovarian-type stroma of pancreatic mucinous cystic neoplasms: Comparative study of subepithelial stromal cells in intraductal papillary mucinous neoplasms of the pancreas.
    Ishida K; Sasano H; Moriya T; Takahashi Y; Sugimoto R; Mue Y; Murakami K; Fujishima F; Nakamura Y; Morikawa T; Motoi F; Suzuki T; Unno M; Sugai T
    Pathol Int; 2016 May; 66(5):281-7. PubMed ID: 27060902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium.
    Wang Y; Sessine MS; Zhai Y; Tipton C; McCool K; Kuick R; Connolly DC; Fearon ER; Cho KR
    J Pathol; 2019 Oct; 249(2):206-214. PubMed ID: 31131879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.
    Thompson LD; Becker RC; Przygodzki RM; Adair CF; Heffess CS
    Am J Surg Pathol; 1999 Jan; 23(1):1-16. PubMed ID: 9888699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cystic neoplasms of the pancreas: update on the surgical pathology and molecular genetics.
    Fukushima N; Zamboni G
    Semin Diagn Pathol; 2014 Nov; 31(6):467-474. PubMed ID: 25441310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian mucinous tumors arising from mature cystic teratomas--a molecular genetic approach for understanding the cellular origin.
    Fujii K; Yamashita Y; Yamamoto T; Takahashi K; Hashimoto K; Miyata T; Kawai K; Kikkawa F; Toyokuni S; Nagasaka T
    Hum Pathol; 2014 Apr; 45(4):717-24. PubMed ID: 24485845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung.
    Silverman JF; Zhu B; Liu Y; Lin X
    Histol Histopathol; 2009 Jan; 24(1):77-82. PubMed ID: 19012247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
    Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
    Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression.
    Fujikura K; Akita M; Abe-Suzuki S; Itoh T; Zen Y
    Histopathology; 2017 Oct; 71(4):591-600. PubMed ID: 28570009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of 29 invasive carcinomas arising in 178 pancreatic mucinous cystic neoplasms with ovarian-type stroma: implications for management and prognosis.
    Jang KT; Park SM; Basturk O; Bagci P; Bandyopadhyay S; Stelow EB; Walters DM; Choi DW; Choi SH; Heo JS; Sarmiento JM; Reid MD; Adsay V
    Am J Surg Pathol; 2015 Feb; 39(2):179-87. PubMed ID: 25517958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
    Fischer CG; Wood LD
    J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
    Conner JR; Mariño-Enríquez A; Mino-Kenudson M; Garcia E; Pitman MB; Sholl LM; Srivastava A; Doyle LA
    Pancreas; 2017; 46(5):665-671. PubMed ID: 28196015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.
    Fukushima N; Sato N; Prasad N; Leach SD; Hruban RH; Goggins M
    Oncogene; 2004 Dec; 23(56):9042-51. PubMed ID: 15489895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.